COVID-19 ECMO Myths Busted

Journal of Cardiac Critical Care TSS

Ujjwal Kumar Chowdhury¹  Amita Sharma²  Sandeep Sharan²  Poonam Malhotra Kapoor² 

[1] Department of CTVS, CTC, AIIMS, New Delhi, India;Department of Cardiac Anaesthesia, CTC, AIIMS, New Delhi, India;

关键词: covid-19;    ecmo;    myths;   

DOI  :  10.1055/s-0040-1713490

来源: DOAJ

【 摘 要 】

Literature has proven that COVID-19 patients develop pneumonia. Prognosis of this is poor in case of COVID-19 patients developing the following: low lymphocyte count (< 16%) which gets lower with active COVID-19 infection, sedentary lifestyle, obesity, and uncontrolled diabetes mellitus with no exercise. A lot of dilemmas and myths in this nascent COVID-19 pandemic period exist regarding the use of ECMO. Perplexities such as do we treat the COVID-19 patients on ECMO, as a pulmonary ARDS pneumonia, and/or do we need high PEEP or moderate PEEP, during ECMO for this ARDS; are some common COVID-19 ECMO myths which this short review aims to cover in a question-answer format.

【 授权许可】

Unknown